Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Autism Recovery Consortium (ARC) is a healthcare-focused organization and educational platform dedicated to promoting biomedical and functional medicine interventions for autism spectrum disorders (ASD). Founded by Dr. Kurt Woeller, the consortium provides clinical resources, practitioner training, and parent guidance centered on addressing the underlying physiological and metabolic factors associated with autism. The organization emphasizes an integrative approach that includes specialized laboratory testing, nutritional supplementation, and dietary modifications to improve developmental outcomes. While not a traditional drug discovery biotech, ARC plays a significant role in the dissemination of integrative treatment protocols and the training of clinicians in functional medicine for neurodevelopmental conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Autism Recovery Consortium.